P
LIVE

Serial Number

79421283

Owner

PADAGIS US LLC

Attorney

Andrea M. Porterfield

Filing Date

Dec 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

P Trademark

Serial Number: 79421283

P is a trademark filed by PADAGIS US LLC on December 19, 2024. The trademark is classified under Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

PADAGIS US LLC (13 trademarks)

1251 Lincoln Road
Allegan, MI 49010

Entity Type: 16

Trademark Details

Filing Date

December 19, 2024

Registration Date

Not Registered

Published for Opposition

February 3, 2026

Goods & Services

Pharmaceutical preparations for the treatment of dermatological, ophthalmic, respiratory, bacterial-based, urological, hormonal, gastrointestinal, cardiovascular, and psychiatric diseases and disorders; pharmaceutical preparations for the treatment of diabetes, migraines, and seizures; pharmaceutical preparations for use in pain management; transdermal patches for use in the treatment of nausea and vomiting; transdermal patches for the delivery of hormonal preparations; pharmaceutical preparations for inhalation for use in treatment of respiratory diseases and disorders and chronic obstructive pulmonary disease (COPD); inhalers sold filled with aerosol inhalation products, namely, antihistamines, decongestants for medical use; nasal and oral spray preparations for use as central nervous system stimulants; anti-infective preparations, namely, pharmaceutical preparations for the treatment of infectious diseases; antiviral preparations, namely, pharmaceutical preparations for the treatment of viral infections; antibiotics; antifungal preparations; anti-inflammatory preparations; cough treatment preparations; topical pharmaceutical and medical preparations for the treatment of vaginal infections; anti-fungal preparations for diaper rash, for antibiotic use, and for the treatment of alopecia; medical gels, creams and lubricants for dermatological use; disposable test strips for measuring blood glucose levels; suppositories being pharmaceutical preparations for hemorrhoids, fever and pain management; oral analgesics; topical analgesics; antacids; antihistamines; cough syrups; cough-expectorants; cough drops; decongestant preparations in the nature of decongestants in the form of tablets, capsules, nasal sprays and medicated oral care solutions and sprays; eye drops; dietary food supplements; laxatives; natural sleeping aid preparations; topical antibiotic creams and ointments; topical pharmaceutical preparations for the treatment of alopecia; pre-moistened medicated wipes; medicated eye pads for medical use; hormonal replacement therapy preparations; hormonal preparations; topical pharmaceutical preparations for hypogonadism; dermal and transdermal pharmaceutical preparations for dermatitis; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; antiparasitic preparations for veterinary purposes; pharmaceutical preparations for the treatment of acne and other skin disorders; pharmaceutical preparations for the treatment of infantile hemangioma; medicated pharmaceutical preparations for the treatment of hemorrhoids, fissure, skin rashes, eczema, fungal infections, and itching; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations for use in oncology and haemato-oncology; pre-filled medical first aid kits and first aid prefilled injection syringes sold filled with pharmaceutical preparations for the treatment of drug overdose, cardiovascular, respiratory, seizure, gastrointestinal, infection, epilepsy, hypogonadism, itching, cold, flu, allergy, and decongestant diseases and disorders, antihistamines, as well as for pain relief and for the treatment of migraines; pharmaceutical preparations, namely, antidepressants; pro-biotic medical preparations, namely, probiotic preparations for medical use; bowel cleansing preparations being bowel evacuant preparations; medicated lozenges and oral cavity throat sprays; pharmaceutical preparations for the treatment of cold sores; pharmaceutical preparations for the treatment of sleeping disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of colds; pharmaceutical preparations for the treatment of flu; pharmaceutical preparations for the treatment of allergy; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; medicated smoking cessation preparations in the nature of gums, lozenges and oral sprays; pharmaceuticals for treating vaginal infections, namely, vaginal antifungals and vaginal suppositories for the prevention and treatment of infections; lubricants for personal use; hygienic preparations for medical use, namely medicated bath preparations for intimate hygiene; vitamin preparations; mineral food-supplements; food supplements for medical use; mineral preparations for medical use; medicinal drinks; pharmaceutical preparations for treating sunburn; pharmaceutical preparations for skin care; pharmaceutical and medicinal preparations for smoking cessation; probiotic supplements

Business management services in relation to wholesale and retail of pharmaceutical, cosmetic, hygiene and beauty products for human use, food supplements and medical apparatus and instruments; demonstration of goods for promotional purposes; distribution of samples; import-export agency services; providing commercial information; sales promotion; promotional and advertising services; public relations; retail store services featuring medical pharmaceutical preparations.

Technical consultancy services in the field of pharmaceutical studies in relation to point-of-care products; product development consultancy services and providing product development services in the nature of technological updates in relation to self-testing products and point of care products; research and development in the fields of pharmaceuticals and medicine; research and development of new products for others; research and development of pharmaceutical preparations; design of pharmaceutical preparations; testing of pharmaceutical preparations

Providing medical consultancy services in relation to self-testing and point-of-care products; medical services; veterinary services; hygienic and beauty care for human beings or animals

Cleaning preparations; hair lotions; shampoos; dentifrices; cosmetic creams; cosmetic preparations for face and body skin care; Non-medicated sun care preparations; cosmetic preparations for personal hygiene; cosmetic preparations for intimate care; non-medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels for the treatment of hemorrhoids, fissure, skin rashes, eczema, fungal infections, and itching; non-medicated skin care preparations for the treatment of hemorrhoids, fissure, skin rashes, eczema, fungal infections, and itching

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 3, 2026 NPUB
PUBLISHED FOR OPPOSITION
Feb 3, 2026 PUBO
NOTIFICATION PROCESSED BY IB
Jan 29, 2026 GPNX
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 28, 2026 NONP
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 14, 2026 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 13, 2026 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 6, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 6, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 6, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 6, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 6, 2026 CNEA
NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
Jan 6, 2026 RDX3
ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
Jan 6, 2026 RDX1
ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
Jan 6, 2026 RRDX
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 5, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Oct 3, 2025 GNFN
FINAL REFUSAL E-MAILED
Oct 3, 2025 GNFR
FINAL REFUSAL WRITTEN
Oct 3, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 16, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 16, 2025 TROA
REFUSAL PROCESSED BY IB
Aug 2, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 11, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jul 11, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
May 15, 2025 RFCR
NON-FINAL ACTION WRITTEN
May 14, 2025 CNRT
ASSIGNED TO EXAMINER
May 13, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 11, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 11, 2025 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 10, 2025 REPR